Contraception

Methotrexate and Misoprostol for Early Abortion: A Multicenter Trial. I. Safety and Efficacy
pp. 321-327(7)
Authors: Creinin M.D.; Vittinghoff E.; Keder L.; Darney P.D.; Tiller G.

Lea's Shield(R): A Study of the Safety and Efficacy of a New Vaginal Barrier Contraceptive Used With and Without Spermicide
pp. 329-335(7)
Authors: Mauck C.; Glover L.H.; Miller E.; Allen S.; Archer D.F.; Blumenthal P.; Rosenzweig B.A.; Dominik R.; Sturgen K.; Cooper J.; Fingerhut F.; Peacock L.; Gabelnick H.L.

Cardiovascular Risk Factors in Norwegian Women Using Oral Contraceptives: Results from a Cardiovascular Health Screening 1985-88
pp. 337-344(8)
Authors: Graff-Iversen S.; Tverdal A.; Stensvold I.

Norplant(R) Implants in the UK: First Year Continuation and Removals
pp. 345-351(7)
Authors: Peers T.; Stevens J.E.; Graham J.; Davey A.

Sperm Transport and Survival Post-application of a New Spermicide Contraceptive
pp. 353-356(4)
Authors: Advantage 24 Study Group; Sangi-Haghpeykar H.; Poindexter A.N.; Levine H.

Effect of Pretreatment Counseling on Discontinuation Rates in Chinese Women Given Depo-medroxyprogesterone Acetate for Contraception
pp. 357-361(5)
Authors: Zhen-Wu L.; Shang C.W.; Garceau R.J.; Sou J.; Qiao-Zhi Y.; Wei-Lun W.; Vander Meulen T.C.

Serum Immunoglobulin Levels During Contraceptive Use of Depot-medroxyprogesterone Acetate in Indian Women: A Preliminary Study
pp. 363-365(3)
Authors: Lali P.; Chandra L.; Gupta R.P.

Tamoxifen and RU39411 Synergize with Mifepristone to Produce Preimplantation Pregnancy Loss by Increasing Embryo Transport (Rat)
pp. 367-373(7)
Authors: Kaplan-Kraicer R.; Kostovetsky I.; Bardin C.W.; Shalgi R.

Purified Neem (Azadirachta indica) Seed Extracts (Praneem) Abrogate Pregnancy in Primates
pp. 375-378(4)
Authors: Mukherjee S.; Lohiya N.K.; Pal R.; Sharma M.G.; Talwar G.P.